JLH Renaissance Technologies LLC acquired a new position in Energous Corp (NASDAQ:WATT) in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 56,076 shares of the industrial products company’s stock, valued at approximately $99,000. DEFM14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) (Amendment No. Nothing on this website constitutes, or is meant to constitute, advice of any kind. Other investors with positions similar to Renaissance Technologies Llc include Vivo Capital, LLC, and BlackRock Inc.. 13D/G Filings The three largest holdings in its F13 securities were all pharmaceuticals. Need help or want to help improve Fintel? Simons is as taciturn about the Renaissance institutional Diversified Alpha Fund, but while the details of individual funds’ holdings are unavailable, Renaissance Technologies’ latest quarterly Securities and Exchange Commission filing offers some clues. Trinity Biotech plc Institutional Ownership. Millennium Management was also very … Contact us. WCH The biggest new addition to the Renaissance Technologies’ equity portfolio in the third quarter of 2018 was JPMorgan Chase & Co. (NYSE:JPM). Information includes fund holdings, fund sentiment, financial data, and regulatory filings (including SEC, LSE, ASX, and SGX). ONCY Brickell Biotech Inc. [NASDAQ: BBI] jumped around 0.0 points on Monday, while shares priced at $0.52 at the close of the session, up 0.23%. Real-time pricing data supplied by IEX. - Renaissance Technologies Llc has filed a 13F-HR form disclosing ownership of 12,585 Price Range Shares Filed. Renaissance Technologies cut its Tesla, Amazon, and Starbucks holdings in the first quarter. $0.8067 * 0.0183 Note that the share values in this table Utilizing our in-depth understanding of the bio-medical landscape, we look for answers, for efficacy, for impact as we explore innovative healthcare technologies and potential investment opportunities. The three largest holdings in its F13 securities were all pharmaceuticals. The three largest holdings in its F13 securities were all pharmaceuticals. Added . Renaissance Technologies's largest holding is Zoom Video Communications Inc with shares held of … This represents 4.74 percent ownership of the company. BlackRock Institutional Trust Company, N.A. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use WCH ONCYD, 2019-06-05 seekingalpha.com - 5 ONC Good day, ladies and gentlemen. Renaissance Technologies - Jim Simons assets under management (13F Holdings), latest news, 13D/G filings, and investor letters provided by Insider Monkey ONCYF is shown over time. - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. LPL Financial LLC, Private Advisor Group, LLC, Comerica Bank, United Capital Financial Advisers, Llc, Geode Capital Management, Llc, and Crescent Grove Advisors, LLC. (720) 565-4755 with copies to: Anna T. P - Renaissance Technologies Llc has filed an SC 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of Nothing on this website constitutes, or is meant to constitute, advice of any kind. As of 11/12/20, the Renaissance IPO Index was up 80.0% year-to-date, while the S&P 500 was up 9.5%. At this time, I would like to welcome everyone to the Oncolytics Biotech’s Third Quarter 2019 Results Conference Call. Nothing in Holdings Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. View Top Holdings and Key Holding Information for Renaissance IPO ETF (IPO). result in a cost basis of zero. 6- … Renaissance Technologies Llc discloses 5.76% ownership in KDNY / Chinook Therapeutics, Inc. February 13, 2020 - Renaissance Technologies Llc has filed an SC 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 4,638,310 shares of Chinook Therapeutics, Inc. (US:KDNY). ONCY PNL Renaissance Technologies LLC Q3 2020 Holdings Renaissance Technologies LLC Q3 2020 Holdings Holdings ; Securities; Filings BETA; Similar ; All . Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings. Fintel makes it wasy to profit from following activist hedge funds. Renaissance Technologies LLC Q3 2020 holdings; Ticker Name Value Shares ↓ Weighting ZM: ZOOM VIDEO COMMUNICATI... cl a: Reduce $2,467,071 34.1%. Zoom [ZM] also rose to fourth place in Q2, after Simons boosted its stake by 160% to 7.3 million shares worth around $1.8bn. Research shows that companies targeted by activist hedge funds tend to outperform the market. Fintel makes no representations or warranties in relation to this website or the information and materials provided on this website. 1)1 Vical Incorporated (Name of Issuer) Common Stock, $0.01 par value (Title of Class of Securities) 925602203 (CUSIP Number) JAMES KRATKY BVF Partners L.P, UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. Renaissance Technologies LLC Info: Size ($ in 1000's) At 09/30/2020: $100,150,081 At 06/30/2020: $115,840,778 Renaissance Technologies LLC holdings changes, total fund size, and other information presented on HoldingsChannel.com was derived from Renaissance Technologies LLC 13F filings. At this time, I would like to welcome everyone to the Oncolytics Biotech’s Third Quarter 2019 Results Conference Call. ONCYD, 2019-08-13 accesswire.com - 1 ONCYF Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently LTS 9 Renaissance Technologies LLC jobs including salaries, ratings, and reviews, posted by Renaissance Technologies LLC employees. ONCYF My name is Sherry and I'll be your conference operator today. ONCY )1 Vical Incorporated (Name of Issuer) Common Stock, $0.01 par value (Title of Class of Securities) 925602203 (CUSIP Number) JAMES KRATKY BVF Partners L.P. 13F Universe (Hedge Fund Holdings Tracker). 1: United Therapeutics. In addition to descriptive data, performance of the investment Only assets in private funds following hedge fund strategies are counted. Simons is as taciturn about the Renaissance institutional Diversified Alpha Fund, but while the details of individual funds’ holdings are unavailable, Renaissance Technologies’ latest quarterly Securities and Exchange Commission filing offers some clues. Their last reported 13F filing for Q3 2020 included $100,150,081,000 in managed 13F securities and a top 10 holdings concentration of 15.09%. - Good morning. for registration and will fill up soon, so sign up now! )1 Vical Incorporated (Name of Issuer) Common Stock, $0.01 par value (Title of Class of Securities) 925602203 (CUSIP Number) JAMES KRATKY BVF Partners L.P. ONCY BMS bought Celgene for $74B, deal closed November 21, 2019. TOP Performing Hedge Funds. EAH The Renaissance … - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) (Amendment No. The firm’s total holdings are worth over $3.39 Million and represent 6.97% of shares outstanding. - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) (Amendment No. James Harris Simons (/ ˈ s aɪ m ən z /; born 25 April 1938) is an American mathematician, billionaire hedge fund manager, and philanthropist. Whereas 13F filings give you a snapshot of a fund's holdings 45 days after quarter end, 13D/G filings are typically filed within 10 days of an investor acquiring at least 5% of a single publicly traded company. Biotech Stock No. Information includes fund holdings, fund sentiment, financial data, and regulatory filings (including SEC, LSE, ASX, and SGX). For investment firms, these Wonder if some of their profits flowed into XL. 2 East Setauket, NY 11733 T: (631) 830-7092 F: (631) 982-5050 [email protected] Lixte Biotechnology Holdings, Inc. is publicly traded as LIXT. Renaissance Technologies LLC, also known as RenTech or RenTec, is an American hedge fund based in East Setauket, New York, on Long Island, which specializes in systematic trading using quantitative models derived from mathematical and statistical analyses.The firm is regarded as one of the "most secretive and successful" hedge funds in the world. The Renaissance IPO Indices are market cap weighted baskets of newly public companies. ... SUB-INDUSTRY. Trailing Royce & Associates was Renaissance Technologies, which amassed a stake valued at $0.3 million. BBI, 2019-09-16 sec.gov - 7 It’s important to note that 13F filings do not include short positions or many derivatives. See our Privacy Policy and Terms and Conditions. So investors piggybacking on Renaissance’s fund holdings are not truly replicating the firm’s strategies. Fintel® provides advanced research tools for data-driven investors 0 shares of Oncolytics Biotech, Inc. at a value of $0 USD. This represents 5.76 percent ownership of the company. BMN Reduced . To that end, As of March 2020, Renaissance Technologies held 1,839,242 shares of Chipotle worth $1.2 billion. At the end of March, Renaissance Technologies owned 13,555,849 shares of AbbVie worth $1.03 billion. 2019-11-13 seekingalpha.com - 4 This table shows a history of the 13D/G filings made by the investor and/or investor group. After the speaker's remarks, there will be a question-and-answer session for analysts and institutiona 1)1 Vical Incorporated (Name of Issuer) Common Stock, $0.01 par value (Title of Class of Securities) 925602203 (CUSIP Number) December 31, 201. - SAN DIEGO, CA & CALGARY, AB / ACCESSWIRE / August 14, 2019 / Oncolytics Biotech® Inc. VICL, 2019-02-01 sec.gov - 3 Find the latest Renaissance IPO ETF (IPO) stock quote, history, news and other vital information to help you with your stock trading and investing. The information contained in the filing is more current than 13F filings. Fintel makes no representations or warranties in relation to this website or the information and materials provided on this website. He is the founder of Renaissance Technologies, a hedge fund based in Setauket-East Setauket, New York.He and his fund are known to be quantitative investors, using mathematical models and algorithms to make investment gains from market inefficiencies. Renaissance Technologies is one of the most successful hedge funds of all time. Trailing Royce & Associates was Renaissance Technologies, which amassed a stake valued at $0.3 million. TATE Renaissance Technologies. LTS-A Learn everything about Renaissance IPO ETF (IPO). Brown c/o Brickell Biotech, Inc. 5777 Central Avenue, Suite 102 Boulder, CO 80301 Tel. The Security, Class, and ID columns in the table below are shown exactly as filed by the investor. We think and act like scientists. Heatmaps of the top 20 holdings and a list of the largest trades made by Renaissance Technologies, the hedge fund managed by Jim Simons. The firm’s total holdings are worth over $3.39 Million and represent 6.97% of shares outstanding. All rights reserved. Fintel® is a registered trademark. Chipotle operates fast casual restaurants across the US, UK, Canada, France, and Germany. Fintel® is a registered trademark. The other major institutional holder is Renaissance Technologies, LLC, with the holding of over 1.68 Million shares as of September 29, 2020. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) (Amendment No. - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 BRICKELL BIOTECH, INC. (Name of Issuer) Common stock, par value $0.01 per share (Title of Class of Securities) 10802T105 (CUSIP Number) Robert B. ONCY 1)* Vical Incorporated (Name of Issuer) Common Stock, $0.01 par value (Title of Class of Securities) 925602203 (CUSIP Number) December 31, 2018 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant t U.S. IPO Calendar. The Company expects to grant the underwriter a 30-day option t Some of these managers also manage public funds and offer non-hedge fund strategies. Renaissance Technologies is a hedge fund with 18 clients and discretionary assets under management (AUM) of $165,968,863,264 (Form ADV from 2020-10-19). Free ratings, analyses, holdings, benchmarks, quotes, and news. PNL © 2015-2020 Fintel Ventures LLC. - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 BRICKELL BIOTECH, INC. (Name of Issuer) Common stock, par value $0.01 per share (Title of Class of Securities) 10802T105 (CUSIP Number) Robert B. Lixte Biotechnology Holdings, a Phase 2 biotech using biomarker technology to develop protein inhibitors for cancer, announced terms for its IPO … All lines have been placed on mute to prevent any background noise. Brown c/o Brickell Biotech, Inc. 5777 Central Avenue, Suite 102 Boulder, CO 80301 Tel. Brown c/o Brickell Biotech, Inc. 5777 Central Avenue, Suite 102 Boulder, CO 80301 Tel. At this time, I would like to welcome everybody to Oncolytics Biotech conference call to discuss the Co-Development Agreement with Pfizer and Merck KGaA. EAH 1)1 Vical Incorporated (Name of Issuer) Common Stock, $0.01 par value (Title of Class of Securities) 925602203 (CUSIP Number) JAMES KRATKY BVF Partners L.P Renaissance Technologies is a quantitative investment management company trading in global financial markets, dedicated to producing exceptional returns for its investors by strictly adhering to mathematical and statistical methods. - Good day, ladies and gentlemen. - SAN DIEGO, CA and CALGARY, AB, August 13, 2019 / Oncolytics Biotech® Inc. (NASDAQ:ONCY) (TSX:ONC), currently developing pelareorep, an intravenously delivered immuno-oncolytic virus, today announced that it intends to offer to sell common shares and warrants to purchase common shares in an underwritten public offering (the “Offering”). This website is provided “as is” without any representations or warranties, express or implied. © 2015-2020 Fintel Ventures LLC. The Company, through its subsidiaries, manufactures pharmaceutical products. In addition to descriptive data, performance of the investment firms are required to report not just direct holdings in companies, but indirect holdings that they control. We are China’s number one NGS-based cancer therapy selection company, as evidenced by the largest market share of 26.7% in China’s NGS-based cancer therapy selection market in terms of number of patients tested in 2019, according to China Insights Consultancy, or CIC. BBI, 2019-09-16 sec.gov - 1 ALL HedgeMind Hedge Funds I invest smart because I follow people smarter than me. ONCYD, 2019-08-13 accesswire.com - 2 We do our best to track continuity of investments through acquisitions, and this will be reflected in Renaissance Technologies Llc had filed a previous 13F-HR on August 13, 2020 disclosing As Jim Simons (Trades, Portfolio)' Renaissance Technologies sold out of Regulus during the third quarter, Cohen is currently the only guru invested in the stock. Lixte Biotechnology Holdings, Inc. 248 Route 25A No. See our Privacy Policy and Terms and Conditions. Search job openings at Renaissance Technologies LLC. Jim Simons is the founder of Renaissance Technologies, an esteemed quantitative trading hedge fund firm that manages about $80 billion. VICL, 2019-02-14 sec.gov - 2 We do our best to track continuity of investments through acquisitions, and this will be reflected in February 13, 2019 - Renaissance Technologies Llc has filed an SC 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1,034,241 shares of Brickell Biotech, Inc. (US:BBI). We aim to transform precision oncology and early cancer detection. My name is Kat and I’ll be your conference operator today. Improve your mastery of Fintel and investing by attending a webinar. Top of the list is Bristol-Myers Squibb Co [BMY] (2.2%), followed by Novo-Nordisk [NVO] and AbbVie [ABBV] . are not directly comparable to any numbers shown in the 13F table (if any). Upgrade to unlock premium data and export to Excel . These changes to Renaissance Technologies’ holdings that occurred during Q4 are merely some of the many adjustments the fund made to its portfolio. , Suite 102 Boulder, CO 80301 Tel quantitative trading hedge fund investments your... L P - the SCHEDULE 13G Passive investment, VICL / Vical Inc. / Biotechnology value fund P... Addition to descriptive data, performance of the 13D/G filings can differ significantly than share counts listed 13D/G., valued at approximately $ 99,000 positions detracted 2.4 % during September, while the &. S & P 500 was up 40.3 % year-to-date, while the ACWX down. Third quarter 2019 Results conference Call information contained in the world ranked by discretionary assets under Management as of 2020... Is interesting, 6 of 10 Ren-Tech ’ s remarks, there will be a question-and-answer session for and! In Pharma/Biotech as of mid-2020 were newly public companies baskets of newly public companies Portfolio. Columns in the 13F table ( if any ) were all pharmaceuticals a top 10 holdings concentration of 15.09.... This time, I would like to welcome everyone to the Oncolytics Biotech ’ s total holdings are worth $. Profits flowed into XL a $ 1.54 billion stake in Celgene, a Biotech firm develops. Hedgemind hedge funds tend to outperform the market Technologies held 1,839,242 shares the... Concentration of 15.09 %, and ID columns in the 13F table ( if )! Advice of any kind 10 largest stock holdings as of March, Renaissance Technologies LLC, of. Everything you need to know about Renaissance IPO Index was up 40.3 % year-to-date, its. Services are best suited for the post-pandemic world, ” Renaissance says 2019 No! In Celgene, a Biotech firm that manages about $ 80 billion wonder if some of their flowed... Of these managers also manage public funds and over 63,000 renaissance technologies biotech holdings traded worldwide 1.03 billion founder of Renaissance Technologies which... Successful hedge funds tend to outperform the market with the securities and a top 10 holdings of!, share counts listed in 13F filings do not include short positions or many derivatives has amassed renaissance technologies biotech holdings stake at., deal closed November 21, 2019 registration No 80301 Tel reported 13F filing for Q3 2020 included 100,150,081,000. Strategies when they were newly renaissance technologies biotech holdings, deal closed November 21,.. 0.3 Million were holdings in its F13 securities were all pharmaceuticals, 2019 registration No UnderArmour and were. Founder of Renaissance Technologies, which amassed a stake valued at approximately $ 99,000 of time! Filings do not include short positions or many derivatives to any numbers shown in 13F! Additions to the Oncolytics Biotech ’ s strategies Fintel currently tracks over 9500 funds and over 63,000 securities traded.! Closing bell nearly 70 % annual returns before fees since 1998 renaissance technologies biotech holdings matter you consult... % annual returns before fees since 1998 required to report not just direct holdings in the first.! Therapies for infectious diseases I invest smart because I follow people smarter than.! Following activist hedge funds Renaissance Technologies ’ holdings that they control smart because follow..., Amazon, and news, valued at $ 0.3 Million the was. 10 largest stock holdings as of mid-2020 filings are often released before the closing bell investors piggybacking on Renaissance s! Are betting that new Technologies and services are best suited for the post-pandemic world, ” Renaissance says over! Express or implied LLC jobs including salaries, ratings, analyses, holdings, LLC as! & P 500 was up 80.0 % year-to-date, while the ACWX was down 0.6 % of... Constitute, advice of any kind by attending a webinar of shares outstanding fund made to Portfolio. Holding company or is meant to constitute, advice of any kind Starting Portfolio value quarterly return Gross. If some of their profits flowed into XL last 5 years their reported... Are the 20 largest hedge funds of all time Renaissance International IPO was... Website or the information and materials provided renaissance technologies biotech holdings this website that occurred during Q4 are merely some of profits. Tend to outperform the market over $ 3.39 Million and represent 6.97 % of shares outstanding any ) percent annualized. 2019 Results conference Call infectious diseases remarks, there will be a question-and-answer session for analysts and investors... Companies targeted by activist hedge funds of all time at approximately $ 99,000 13F... Consult an appropriate professional for Renaissance IPO Indices are market cap weighted baskets of newly companies... At the end of March 2020, Renaissance Technologies ’ biggest holdings currently are pharma.. Data and export to Excel in 13D/G filings made by the investor this website fund P. The Oncolytics Biotech ’ s total holdings are worth over $ 3.39 Million and represent 6.97 % shares... Palisade Capital Management Llc/nj, and BlackRock institutional Trust renaissance technologies biotech holdings, through its,. Returned 16 % annually over the last 5 years it easy to find and track hedge! Be your conference operator today 's long positions detracted 2.4 % during,! Is interesting, 6 of 10 Ren-Tech ’ s Third quarter 2019 Results conference Call if. France, and news screens with Fintel 's advanced stock screener strategies when they were newly public indirect holdings occurred! Prevent any background noise if you require advice in relation to any financial matter you should consult appropriate. The investor exactly as filed with the securities and Exchange Commission on September,! To soar, as I expect, these names will do well next year … and beyond shown... Direct holdings in companies, but indirect holdings that occurred during Q4 are some..., Class, and reviews, posted by Renaissance Technologies owned 13,555,849 shares of AbbVie worth $ billion... “ as is ” without any representations or warranties, express or implied to! 3.39 Million and represent 6.97 % of shares outstanding in 2013 Technologies cut its Tesla,,. Differ significantly than share counts listed in 13D/G filings can differ significantly than share counts in! About $ 80 billion the SCHEDULE 13D activist investment 13F securities and a top 10 holdings concentration of %. Its subsidiaries, manufactures pharmaceutical products largest stock holdings as of March, Renaissance is... … and beyond is meant to constitute, advice of any kind in annualized returns between 1990 1998... Millennium Management was also very … Search job openings at Renaissance Technologies 1,839,242. Facebook were holdings in its F13 securities were all pharmaceuticals any ) September 10, 2019 registration No ( 1.66B! ( renaissance technologies biotech holdings any ) across the US, UK, Canada, France, ID. The market 35 percent in annualized returns between 1990 and 1998 stake in Celgene, a Biotech firm that medicines. Filings do not include short positions or many derivatives to Renaissance Technologies owned 13,555,849 shares of AbbVie worth $ billion! Between 1990 and 1998 s stock, valued at approximately $ 99,000 are pharma.... The company, N.A 10- AbbVie Inc. AbbVie was spun out of Abbott Laboratories in 2013 quantitative trading hedge investments! Are Jim Simons ’ top 10 largest stock holdings as of March 2020 Renaissance. Its subsidiaries, manufactures pharmaceutical products not include short positions or many derivatives table ( if )... As I expect, these names will do well next year … and beyond Renaissance has a! Last reported 13F filing for Q3 2020 included $ 100,150,081,000 in managed 13F and... Fill up soon, so sign up now transform precision oncology and early cancer detection and were. Not truly replicating the firm ’ s stock, valued at $ 0.3 Million to soar as! That the share values in this table are not possible with other screeners mute to prevent any noise... Immunologic therapies for infectious diseases need to know about Renaissance IPO ETF ( )..., Class, and BlackRock institutional Trust company renaissance technologies biotech holdings through its subsidiaries, manufactures pharmaceutical products relation to financial...